| Financial Year |
March 31 2023 |
| Monetary Funds |
422,924,008.65 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
33,081,419.30 |
| Accounts Receivable |
806,053,968.01 |
| Advances to Suppliers |
12,291,051.59 |
| Other Receivables |
24,226,466.90 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
221,019,207.06 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
98,244,983.41 |
| Total Current Assets |
1,757,223,804.47 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
113,632,771.16 |
| Fixed Assetes |
151,934,238.72 |
| Under-construction Projects |
42,955,873.15 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
23,799,033.58 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
7,766.94 |
| Deferred Income Tax Assets |
29,106,278.11 |
| Other Non-Current Assets |
15,800,046.60 |
| Sub-Total of Non-Current Assets |
427,181,895.35 |
| Total Assets |
2,184,405,699.82 |
| Short-Term Loans |
303,096,428.91 |
| Trading Financial liabilities |
-- |
| Notes Payable |
381,502,781.57 |
| Accounts Payable |
43,883,714.62 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
4,280,637.27 |
| Taxes Payable |
7,516,664.44 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
11,098,163.81 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,891,573.17 |
| Other Current Liabilities |
3,999,891.06 |
| Sub-Total of Current Liabilities |
769,961,324.47 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
28,139,920.17 |
| Special Payable |
-- |
| Estimatied Liabilities |
750,000.00 |
| Deferred Income Tax Liabilities |
14,471,761.79 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
101,080,651.18 |
| Total Liabilities |
871,041,975.65 |
| Paid-In Capital(Or Share Stock) |
250,616,000.00 |
| Capital Surplus |
616,998,707.78 |
| Surplus Reserve |
37,234,504.01 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
408,777,301.50 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,313,363,724.17 |
| Owner's Equity（Stockholder's Equity） |
1,313,363,724.17 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,184,405,699.82 |
